v3.26.1
Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net income (loss) $ 2,132,715 $ 1,193,616
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Prepaid expenses 164,190 33,236
Interest income earned in cash and investments held in Trust Account (2,683,684) (1,456,287)
Change in operating assets and liabilities:    
Prepaid expenses (219,190) (70,448)
Accrued expenses 45,451 27,387
Amount due to Sponsor 149,550 75,744
Net cash used in operating activities (410,968) (196,752)
Cash flows from investing activities:    
Investment of cash in Trust Account (69,000,000)
Cash withdrawn from Trust Account to redeem Public Shares 55,413,505  
Extension contributions deposited into Trust Account (150,000)  
Net cash provided by(used in) investing activities 55,263,505 (69,000,000)
Cash flows from financing activities:    
Payments for common stock redemption (55,413,505)  
Proceeds from promissory note - related party 150,000  
Proceeds from issuance of Founder Shares to Sponsor 25,000
Sale of units to the founder in private placement 2,069,000
Proceeds from issuance promissory note 298,440
Proceeds from sale of units 69,000,000
Payment of offering costs (1,485,819)
Payment of promissory note to Sponsor (298,440)
Net cash used in(provided by) financing activities (55,263,505) 69,608,181
Net change in Cash (410,968) 411,429
Cash at beginning of period 411,429
Cash and cash equivalents at end of year 461 411,429
Non-cash investing and financing activities    
Deferred underwriting compensation 690,000
Initial value of ordinary share subject to possible redemption 62,100,000
Reclassification of offering costs related to public shares (1,958,237)
Subsequent measurement of ordinary shares subject to redemption against additional paid-in capital (“APIC”) and accumulated deficit 150,000 8,858,237
Subsequent measurement of ordinary shares subject to redemption (interest earned in Trust Account) 2,683,684 1,456,287
Representative shares issued to underwriter $ 7